Yi Hang
Internal Medicine Residency · University of Pennsylvania Health System
Credentials: ·
History
Research
Venetoclax with decitabine or azacitidine in the first-line treatment of acute myeloid leukemia
eJHaem · 2023 · 21 citations
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia
Medical Oncology · 2024 · 12 citations
Immune Checkpoint Inhibitor Rechallenge in a Patient With Previous Fulminant Myocarditis
Case report · The American Journal of Cardiology · 2023 · 10 citations
- GM
4 papers · 4 as a resident
4 papers · 4 as a fellow
- JB
4 papers · 4 as a resident
4 papers · 4 as a resident
4 papers
- MD
4 papers
- SG
4 papers
4 papers · 4 as a resident
